Ovarian Cancer FAQ
Ovarian Cancer FAQ
The conceptual questions — types, stages, why surgery or chemotherapy first — are answered on the other pages of this guide. This page covers what patients actually need to organise: what treatment costs relative to home, how long you stay, what to bring, and what life after treatment looks like.
What treatment costs
The network's published position: treatment in China runs at roughly 30%–50% of the equivalent treatment in Europe or the US. The range is honest rather than exact, because what you pay depends on the route — a fertility-sparing stage I operation, a full debulking with bowel resection, and a six-cycle chemotherapy course with maintenance are different orders of cost — and on the drug component of maintenance therapy.
What the network commits to is the structure: a written, itemised estimate after your records are reviewed, before you travel. No figure quoted on a website or by phone replaces that estimate, because it is built on the actual planned route — and the route, as this guide sets out, depends on the resectability assessment and the genotype. Ask for the estimate in writing and hold the plan to it.
How long you stay
Length of stay follows the route. Debulking surgery means one to two weeks in hospital, with recovery before flying measured in several weeks and discussed case by case — longer where bowel was resected. Chemotherapy is an outpatient course: six cycles of carboplatin–paclitaxel at three-week intervals, meaning patients base themselves near the hospital for roughly four to five months, which the international service helps arrange. PARP maintenance is tablets at home, with remote follow-up through the international service.
The planning point: the surgery-first and chemotherapy-first routes have different calendars from each other, and the maintenance phase is where most of the stay-after-treatment happens — at home. The file is reviewed before flights are booked, whichever route applies.
Medicines to bring
Bring your regular medicines in original packaging with a doctor's letter, in quantities covering the first weeks. Three points specific to this disease: anti-sickness and pain medication you already rely on, since prescriptions are re-established locally rather than assumed; hormone therapy, if you take it, flagged in advance because surgical menopause changes the conversation; and anything taken for a genetic condition or prior cancer, documented with doses. Anything infusion-based — chemotherapy, bevacizumab — and the PARP maintenance tablets are provided at the hospital and need not travel with you.
Records to prepare
The file that lets a gynaecological oncology MDT answer within 48 hours contains five items:
- The imaging itself — pelvic ultrasound report plus the CT discs or links, not only reports
- CA-125 (and HE4) values over time, as a trend rather than a single number
- The pathology or cytology report, and the paraffin blocks where tissue exists
- Genetic results — germline BRCA, tumour BRCA/HRD — or the agreement to test here
- Anything already treated: operation notes, chemotherapy cycles and dates, maintenance started
The most commonly missing items are the imaging itself and the paraffin blocks, and they are the two the resectability assessment and the genotype question turn on. Reports without discs allow a provisional view; they do not allow a sequence.
Insurance and direct billing
The network holds direct-billing relationships with more than 55 international insurers, which means eligible policies are settled between insurer and hospital rather than by the patient upfront. What to do before travelling: confirm with your insurer that treatment at the specific hospital is covered, ask whether pre-authorisation is required for surgery or chemotherapy, and bring the policy number and authorisation letter. The international service checks eligibility in advance of arrival, not after it. Out-of-pocket patients receive the itemised estimate described above and settle against it directly.
Life after treatment
Follow-up after ovarian cancer treatment has two registers. For epithelial disease in remission: CA-125 trends, examinations and imaging on a defined schedule, with maintenance therapy continued and monitored — blood counts and clinic reviews for PARP inhibitors, blood pressure checks for bevacizumab. For women after risk-reducing or fertility-sparing surgery: the menopause and hormone questions managed deliberately, and fertility follow-up with obstetric input where the uterus remains.
The second register is ordinary life: work, travel and exercise resume on timelines that depend on the route, and the follow-up calendar is built around them rather than the reverse. Ask for the follow-up plan and the maintenance schedule in writing before you fly home — for a treatment whose longest phase is tablets at home, that written plan is the treatment.
Eating during treatment
Nutrition through chemotherapy is planned before the first cycle, because the regimen suppresses appetite and the disease itself causes early satiety — a combination that loses weight quietly. The working principles: small frequent meals rather than three large ones, protein at every meal, and weight recorded weekly so the trend is visible; mouth care and taste changes are managed with the dietitian rather than endured. A dietitian sees patients on treatment at this network as a matter of course, and adjustments are made at each cycle review rather than after problems accumulate. After treatment, no special diet is required — the goal is a return to ordinary, adequate eating, monitored through the follow-up weights.